---
figid: PMC6689672__00117-2019.03
figtitle: Differential pathway regulation in advanced idiopathic pulmonary fibrosis
  (IPF) lung
organisms:
- Homo sapiens
- Mus musculus
- Byrsonima crassifolia
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6689672
filename: 00117-2019.03.jpg
figlink: /pmc/articles/PMC6689672/figure/F3/
number: F3
caption: 'Differential pathway regulation in advanced idiopathic pulmonary fibrosis
  (IPF) lung. a) Metacore analyses of pathway enrichment in IPF versus control lungs
  using a filter of positive and negative fold change ≥2 and adjusted p-value of ≤0.001.
  b) Genego pathway map of tumour-infiltrating T-cells showing selected markers and
  key effector molecules. c) Genego pathway map of myeloid-derived suppressor cells
  in cancer. Red and blue thermometers indicate pathway components showing increased
  or decreased expression in IPF respectively. ECM: extracellular matrix; IP10: 10-kDa
  interferon-γ-inducible protein; MIG: monokine induced by interferon-γ; I-TAC: interferon-inducible
  T-cell α-chemoattractant; MIP: macrophage inflammatory protein; Th: T-helper; STAT:
  signal transducer and activator of transcription; TCR: T-cell receptor; TNFR: tumour
  necrosis factor receptor; Tfh: T-follicular helper; IRF: interferon regulatory factor;
  ROR: RAR-related orphan receptor; CTLA: cytotoxic T-lymphocyte-associated protein;
  PD: programmed death receptor; LAG: lymphocyte activation gene product; IFN: interferon;
  IL: interleukin; SDF: stromal cell-derived factor; GRO: growth-related oncogene
  protein; ENA: epithelium-derived neutrophil-activating protein; RAGE: receptor of
  advanced glycosylation end-products; IL8R: interleukin-8 receptor; M-MDSC: monocytic
  myeloid-derived suppressor cell; G-MDSC: granulocytic myeloid-derived suppressor
  cell; ITGAM: integrin subunit αM; FUT: fucosyltransferase; MHC: major histocompatibility
  complex; TNFRSF: tumour necrosis factor receptor superfamily; NF-κB: nuclear factor,
  κ-light chain enhancer of activated B-cells; TGF: transforming growth factor.'
papertitle: RNA sequencing of transplant-stage idiopathic pulmonary fibrosis lung
  reveals unique pathway regulation.
reftext: Pitchumani Sivakumar, et al. ERJ Open Res. 2019 Jul;5(3):00117-2019.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6104336
figid_alias: PMC6689672__F3
figtype: Figure
redirect_from: /figures/PMC6689672__F3
ndex: 411000e5-df35-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6689672__00117-2019.03.html
  '@type': Dataset
  description: 'Differential pathway regulation in advanced idiopathic pulmonary fibrosis
    (IPF) lung. a) Metacore analyses of pathway enrichment in IPF versus control lungs
    using a filter of positive and negative fold change ≥2 and adjusted p-value of
    ≤0.001. b) Genego pathway map of tumour-infiltrating T-cells showing selected
    markers and key effector molecules. c) Genego pathway map of myeloid-derived suppressor
    cells in cancer. Red and blue thermometers indicate pathway components showing
    increased or decreased expression in IPF respectively. ECM: extracellular matrix;
    IP10: 10-kDa interferon-γ-inducible protein; MIG: monokine induced by interferon-γ;
    I-TAC: interferon-inducible T-cell α-chemoattractant; MIP: macrophage inflammatory
    protein; Th: T-helper; STAT: signal transducer and activator of transcription;
    TCR: T-cell receptor; TNFR: tumour necrosis factor receptor; Tfh: T-follicular
    helper; IRF: interferon regulatory factor; ROR: RAR-related orphan receptor; CTLA:
    cytotoxic T-lymphocyte-associated protein; PD: programmed death receptor; LAG:
    lymphocyte activation gene product; IFN: interferon; IL: interleukin; SDF: stromal
    cell-derived factor; GRO: growth-related oncogene protein; ENA: epithelium-derived
    neutrophil-activating protein; RAGE: receptor of advanced glycosylation end-products;
    IL8R: interleukin-8 receptor; M-MDSC: monocytic myeloid-derived suppressor cell;
    G-MDSC: granulocytic myeloid-derived suppressor cell; ITGAM: integrin subunit
    αM; FUT: fucosyltransferase; MHC: major histocompatibility complex; TNFRSF: tumour
    necrosis factor receptor superfamily; NF-κB: nuclear factor, κ-light chain enhancer
    of activated B-cells; TGF: transforming growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hbb-b1
  - B3gnt9
  - Cxcl9
  - Ccl20
  - Cxcl16
  - Ccl4
  - Cxcl13
  - Gsr
  - Ly6g
  - Cxcr3
  - Cxcl5
  - Hand1
  - Nelfcd
  - Cxcr4
  - Cxcr5
  - Ager
  - Mok
  - Cda
  - Tbx21
  - .na.character
  - Cd14
  - Hand2
  - Qrsl1
  - Bc1
  - Bc1-ps1
  - Igkv1-136
  - Ahr
  - Cd33
  - Stat3
  - Spi1
  - Itgam
  - Stat6
  - Fut4
  - Nfkb1
  - Il2
  - Il4
  - Il5
  - Il13
  - Th
  - Il10
  - Tgfb1
  - Ltbp1
  - Cxcl10
  - Gata3
  - Arhgef7
  - Ctla4
  - Il17a
  - B3GNT2
  - B3GNTL1
  - UPK1A
  - CXCL9
  - RPS6KA3
  - CRLS1
  - CCL20
  - CXCL16
  - CCL4
  - CCL4L1
  - DCAF13
  - LLCFC1
  - CXCL13
  - CXCL1
  - TRIT1
  - CXCL2
  - CXCR3
  - CXCL5
  - NELFCD
  - CXCR4
  - CXCR5
  - AGER
  - MOK
  - CDA
  - TBX21
  - COPD
  - ARCN1
  - CD14
  - NDUFA2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - QRSL1
  - GATA1
  - GATA2
  - GATA3
  - GATA4
  - GATA5
  - GATA6
  - CHMP2A
  - HLA-C
  - AHR
  - CD33
  - SPI1
  - ITGAM
  - ITPR1
  - FUT4
  - NFKB1
  - CEACAM8
  - IL2
  - IL4
  - IL5
  - IL13
  - TH
  - IL10
  - TGFB1
  - TGFB2
  - TGFB3
  - CXCL10
  - LINC-ROR
  - ROR1
  - ROR2
  - CTLA4
  - IL17A
  - Bl
  - egh
  - LanB1
  - betaTub56D
  - mys
  - Prosbeta1
  - bi
  - cg
  - CLS
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - TH1
  - Low
  - Stat92E
  - GatA
  - srp
  - pnr
  - tc
  - bc2
  - BC1
  - Mhc
  - zip
  - ss
  - tth
  - Dif
  - dl
  - Rel
  - Cds
  - cd-s
  - dpp
  - gbb
  - put
  - mav
  - upt
  - tu(3)be
  - Ror
  - CO40
  - ITGAM
  - cancer
---
